Carrillo, MD, discusses results of a study which sought to assess the association between thymectomy and incidence of renal ...

The FDA issued a ‘safe to proceed’ for the investigational new drug application for PRAME TCR/IL-15 NK for relapsed or ...

Recently published guidelines from the FDA aim to expand eligibility criteria in clinical trials with recommendations for ...

Although immune checkpoint inhibitors have become a cornerstone of therapy across cancer settings, their use in most breast ...

A recent article pointed out that efforts to decrease low-value care often fall short. It asserted that a primary cause is physicians being financially motivated. I do not deny that profiting from a ...

Lucia Masarova, MD, PhD, elaborated on the latest updates across myeloproliferative neoplasms, focusing on significant ...

Updated guidelines for small cell lung cancer were developed with an expert panel assembled by the American Society of ...

Lori J. Wirth, MD, discusses some of the ongoing clinical trials investigating innovative therapies or combinations for the ...

During a live Community Case Forum event in partnership with the Tennessee Oncology Practice Society, Pierre Gholam, MD, ...

Recent FDA approvals such as tovorafenib, nogapendekin, and alectinib, are included in this recap. We also cover boxed warnings for CAR T-cell therapies and analysis advancements for papillary thyroid ...

Targeted therapies and immunotherapies across the ovarian, endometrial, and cervical cancers landscape play expanded roles, ...

CASE SUMMARY An African American woman aged 59 years presented with a left renal mass. She underwent left radical nephrectomy, which revealed clear cell RCC. Nine months later, she developed nodules ...